Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 266.89bn | 284.31bn | 316.62bn | 381.31bn | 261.50bn | 180.54bn | 344.88bn |
| Research and development | 1.17bn | 1.10bn | 1.29bn | 1.08bn | 815m | 907m | 962m |
| Selling, general and administrative | 12.61bn | 12.44bn | 13.43bn | 12.88bn | 11.33bn | 9.88bn | 10.49bn |
| Interest expense | 4.67bn | 4.79bn | 4.67bn | 3.18bn | 3.61bn | 4.09bn | 4.69bn |
| Pre-tax income | 29.76bn | 29.92bn | 32.63bn | 64.82bn | 29.83bn | −26.97bn | 25.49bn |
| Income tax | 11.64bn | 13.40bn | 12.99bn | 21.94bn | 9.20bn | −5.43bn | 9.05bn |
| Net income | 18.12bn | 16.52bn | 19.64bn | 42.87bn | 20.63bn | −21.53bn | 16.43bn |
| Weighted average shares | 5.95bn | 6.36bn | 6.80bn | 7.41bn | 7.81bn | 7.80bn | 8.11bn |
| Metric | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 30.22bn | 39.11bn | 38.77bn | 40.25bn | 36.97bn | 31.83bn | 18.06bn |
| Receivables | — | 44.60bn | 45.86bn | 53.27bn | 66.51bn | 34.72bn | 21.78bn | 30.22bn |
| Inventory | — | 22.22bn | 23.43bn | 26.02bn | 31.89bn | 25.26bn | 19.46bn | 24.07bn |
| Current assets | — | 107.17bn | 127.93bn | 134.12bn | 165.94bn | 128.77bn | 91.95bn | 92.69bn |
| Property, plant and equipment | — | — | — | — | 198.64bn | 194.93bn | 209.70bn | 238.35bn |
| Goodwill | — | 15.66bn | 16.03bn | 16.66bn | 16.04bn | 14.92bn | — | — |
| Total assets | — | 370.35bn | 387.61bn | 406.27bn | 443.02bn | 404.38bn | 379.27bn | 404.34bn |
| Current liabilities | — | 82.42bn | 95.03bn | 95.47bn | 121.31bn | 95.55bn | 73.71bn | 79.62bn |
| Short-term debt | — | 9.13bn | 11.63bn | 9.93bn | 9.00bn | 8.22bn | 16.90bn | 15.06bn |
| Long-term debt | — | 66.52bn | 65.45bn | 71.61bn | 74.79bn | 80.87bn | 91.12bn | 81.36bn |
| Total liabilities | — | 195.03bn | 207.44bn | 217.91bn | 250.43bn | 229.05bn | 220.73bn | 213.87bn |
| Equity | — | 175.32bn | 180.17bn | 188.36bn | 192.60bn | 175.33bn | 158.54bn | 190.46bn |
| Shares outstanding | — | 5.69bn | 6.08bn | 6.49bn | 6.97bn | — | — | — |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 42.86bn | 54.69bn | 54.19bn | 68.41bn | 45.10bn | 34.11bn | 42.18bn |
| Depreciation and amortisation | 25.30bn | 26.87bn | 31.29bn | 18.53bn | 26.92bn | 52.44bn | 28.70bn |
| Investing cash flow | −16.81bn | −15.16bn | −17.73bn | −22.45bn | −4.76bn | −13.28bn | −15.78bn |
| Financing cash flow | −35.81bn | −38.44bn | −38.24bn | −41.95bn | −34.66bn | −7.22bn | −35.21bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)